Hoppa till innehåll
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Språk
Alla fält
Titel
Upphovsman
Ämne
Signum
ISBN/ISSN
Tagg
Sök
Avancerad
Zoledronic acid inhibits the d...
Hänvisa
Textmeddelande
Skicka per e-post
Skriv ut
Exportera posten
Exportera till: RefWorks
Exportera till: EndNoteWeb
Exportera till: EndNote
Permanent länk
Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.
Bibliografiska uppgifter
Huvudupphovsmän:
Croucher, P
,
Hijzen, A
,
Shipman, C
,
Perry, M
,
Lippitt, J
,
Green, J
,
Van Camp, B
,
Vanderkerken, K
Materialtyp:
Journal article
Publicerad:
2001
Beståndsuppgifter
Beskrivning
Liknande verk
Katalogiseringsuppgifter
Beskrivning
Sammanfattning:
Liknande verk
Zoledronic acid prevents the development of osteolytic bone disease and increases survival in a murine model of multiple myeloma
av: Croucher, P, et al.
Publicerad: (2002)
Zoledronic acid prevents the development of myeloma bone disease and increases survival
av: Shipman, C, et al.
Publicerad: (2002)
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
av: Croucher, P, et al.
Publicerad: (2001)
Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
av: Croucher, P, et al.
Publicerad: (2001)
Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival.
av: Croucher, P, et al.
Publicerad: (2003)